Bristol-Myers wins FDA nod for novel antipsychotic

27 set 2024 · 5 min. 1 sec.

Descrizione

Bristol-Myers (BMY) wins https://seekingalpha.com/news/4153957-bristol-myers-wins-fda-nod-for-first-of-its-kind-antipsychotic?source=wsb_podcast:bristol_myers_wins_fda_nod_for_novel_antipsychotic for first-of-its-kind antipsychotic. (00:25) DirecTV, Dish (SATS) close in on https://seekingalpha.com/news/4153963-directv-dish-close-in-on-merger-to-form-largest-us-pay-tv-service-bloomberg?source=wsb_podcast:bristol_myers_wins_fda_nod_for_novel_antipsychotic to form largest US pay-TV service: Bloomberg. (01:11) Major Trump Media (DJT) shareholder https://seekingalpha.com/news/4153942-major-trump-media-shareholder-dumps-nearly-entire-stake?source=wsb_podcast:bristol_myers_wins_fda_nod_for_novel_antipsychotic nearly...

mostra di più

Bristol-Myers (BMY) wins FDA nod for first-of-its-kind antipsychotic. (00:25) DirecTV, Dish (SATS) close in on merger to form largest US pay-TV service: Bloomberg. (01:11) Major Trump Media (DJT) shareholder dumps nearly entire stake. (02:18)

Episode transcripts seekingalpha.com/wsb.

Show links:
Hurricane Helene misses 'most prolific' Gulf of Mexico oil and gas producing areas
U.S. and Intel could close $8.5B chip funding by year-end - report
Intel said to rebuff approach by Arm Holdings for product unit

Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.

mostra meno